OpGen Inc Share Price Nasdaq
Equities
US68373L1098
Biotechnology & Medical Research
Sales 2022 | 2.61M 206M | Sales 2023 | 3.42M 270M | Capitalization | 4.21M 332M |
---|---|---|---|---|---|
Net income 2022 | -37M -2.92B | Net income 2023 | -32M -2.53B | EV / Sales 2022 | 5.74 x |
Net Debt 2022 | 7.38M 583M | Net Debt 2023 | 11.89M 940M | EV / Sales 2023 | 4.71 x |
P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-0.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Latest transcript on OpGen Inc
Managers | Title | Age | Since |
---|---|---|---|
Oliver Schacht
PRN | Corporate Officer/Principal | 53 | 31/03/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Oliver Schacht
PRN | Corporate Officer/Principal | 53 | 31/03/20 |
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |